Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rose who wrote (417)	3/19/2000 2:46:00 AM
From: Doc Bones	Respond to of 3559

While I would never "toot my own horn" in this space, I think a careful review of my oeuvre on SI would lead any unbiased reader to the inescapable conclusion that my analysis of biotech is "invaluable." Perhaps the ultimate tribute to my combined scientific/business acumen is to be found in my own thriving enterprise: the "Doc Bones" label offers a full line of tonics, elixirs, and, of course, snake oils. If you're not a zealot about so-called "FDA Approval", I can speed a catalog your way today. Catalog price refunded with first purchase. "Sincerely" Yours Doc

To: Robert Rose who wrote (417)	3/20/2000 6:55:00 AM
From: Micawber	Read Replies (1) \| Respond to of 3559

>>Still working on identifying the folks up to speed on both fields here at SI. I have a couple prospects.<< In the "right under your nose" department: To: Cheryl Galt who wrote (656) From: Richard Harmon Saturday, Feb 26, 2000 4:45 PM ET Reply # of 665 2. Nobody, period, had a better 1999 than Miljenko. The original T/FIF thread named V1/Silverman/Suzman as biotech's investors of 1998. We have to give 1999 to Miljenko, on the combined strength of analysis and performance. Unmatched. THANKS, MZ! Next breath..... Dave's "Blind Squirrel" should be turned into a screen play. Same rationale for Larry, Marc and others who had huge years...... unbelievable performance, but insufficient analysis to knock MZ out of sole possession of the honor. I encourage "new blood" to take the lead with the new thread, as Dave and Mike volunteered last time. 3. The contributors to this thread represent lots of what's good in this world. Let's help Mike's daughter take it forward in fine style. I realize that some will object to the arrogance of my pronouncing who is biotech's investor of the year. Tough, live with it. For those who object to picking the year's best biotech investor from among the ranks at SI, "open your eyes". Thanks all, getting ready to wind down this thread as we wound down T/FIF I......... with congratulations all around. Rick You've been addressing your questions to one of the best. McCammant isn't even on the radar screen.